Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Transl Psychiatry
2022 May 19;121:208. doi: 10.1038/s41398-022-01970-6.
Show Gene links
Show Anatomy links
Anxiolytic and antidepressants' effect of Crataegus pinnatifida (Shan Zha): biochemical mechanisms.
Nitzan K
,
David D
,
Franko M
,
Toledano R
,
Fidelman S
,
Tenenbaum YS
,
Blonder M
,
Armoza-Eilat S
,
Shamir A
,
Rehavi M
,
Ben-Chaim Y
,
Doron R
.
???displayArticle.abstract???
Depression and anxiety disorders are highly prevalent. Selective serotonin reuptake inhibitors (SSRIs) are the current first-line treatment for depression, but they have pronounced limitations. Traditional Chinese medicine can serve as a safe and effective alternative to conventional drugs, particularly since many herbal remedies have already been approved for human use as food additives, making the transition from bench to bedside more efficient. We previously demonstrated that a novel herbal treatment (NHT) induces anxiolytic- and antidepressant-like effects. NHT consists of four herbs: Crataegus pinnatifida (Shan Zha), Triticum aestivum (Fu Xiao Mai), Lilium brownii (Baihe), and the fruit of Ziziphus jujuba (Da Zao). In the current study, we examined the antidepressant-like and anxiolytic-like activities of each individual herb on stressed mice and compared those to the effects of NHT and escitalopram. We show here that Shan Zha is sufficient to produce an anxiolytic and antidepressant-like effect similar to NHT or the escitalopram through activation of 5-HT1A receptor and an elevation in BDNF levels in the hippocampus and Pre-frontal cortex (PFC). Chronic treatment with Shan Zha did not alter serotonin transporter levels in the PFC, as opposed to escitalopram treatment. These results were confirmed in vitro, as none of the herbs blocked SERT activity in Xenopus oocytes. Notably, Shan Zha is sold as a nutritional supplement; thus, its transition to clinical trials can be easier. Once its efficacy and safety are substantiated, Shan Zha may serve as an alternative to conventional antidepressants.
Avitsur,
Escitalopram or novel herbal treatments differentially alter cytokine and behavioral responses to immune challenge.
2017, Pubmed
Avitsur,
Escitalopram or novel herbal treatments differentially alter cytokine and behavioral responses to immune challenge.
2017,
Pubmed
Baker-Herman,
BDNF is necessary and sufficient for spinal respiratory plasticity following intermittent hypoxia.
2004,
Pubmed
Barbui,
Review: maintenance antidepressants reduce risk of relapse but effect is not as great in recurrent depression.
2009,
Pubmed
Baxter,
Global prevalence of anxiety disorders: a systematic review and meta-regression.
2013,
Pubmed
Ben-Chaim,
The M2 muscarinic G-protein-coupled receptor is voltage-sensitive.
2003,
Pubmed
,
Xenbase
Björkholm,
BDNF - a key transducer of antidepressant effects.
2016,
Pubmed
Burke,
Sensitivity of hippocampal 5-HT1A receptors to mild stress in BDNF-deficient mice.
2013,
Pubmed
Burstein,
Patients' attitudes toward conventional and herbal treatments for depression and anxiety: A cross-sectional Israeli survey.
2022,
Pubmed
Burstein,
Escitalopram and NHT normalized stress-induced anhedonia and molecular neuroadaptations in a mouse model of depression.
2017,
Pubmed
Burstein,
The Unpredictable Chronic Mild Stress Protocol for Inducing Anhedonia in Mice.
2018,
Pubmed
Burstein,
Moderation of the transgenerational transference of antenatal stress-induced anxiety.
2021,
Pubmed
Butterweck,
Flavonoids of St. John's Wort reduce HPA axis function in the rat.
2004,
Pubmed
Chakrapani,
Neuroplasticity and the Biological Role of Brain Derived Neurotrophic Factor in the Pathophysiology and Management of Depression.
2020,
Pubmed
Chang,
Hawthorn.
2002,
Pubmed
Colucci-D'Amato,
Neurotrophic Factor BDNF, Physiological Functions and Therapeutic Potential in Depression, Neurodegeneration and Brain Cancer.
2020,
Pubmed
Cui,
Polyphenolic content and physiological activities of Chinese hawthorn extracts.
2006,
Pubmed
Doron,
A novel herbal treatment reduces depressive-like behaviors and increases BDNF levels in the brain of stressed mice.
2014,
Pubmed
Doron,
GABAA Receptor Density Is Not Altered by a Novel Herbal Anxiolytic Treatment.
2018,
Pubmed
Doron,
Cerebral MAO Activity Is Not Altered by a Novel Herbal Antidepressant Treatment.
2019,
Pubmed
Doron,
Escitalopram or novel herbal mixture treatments during or following exposure to stress reduce anxiety-like behavior through corticosterone and BDNF modifications.
2014,
Pubmed
Doron,
Anxiolytic effects of a novel herbal treatment in mice models of anxiety.
2012,
Pubmed
Du,
Metabonomic identification of the effects of the Zhimu-Baihe saponins on a chronic unpredictable mild stress-induced rat model of depression.
2016,
Pubmed
Farach,
Pharmacological treatment of anxiety disorders: current treatments and future directions.
2012,
Pubmed
Giladi,
Curcumin potentiates the pro-apoptotic effects of sulindac sulfone in colorectal cancer.
2010,
Pubmed
Gisunterman,
[DISRUPTIVE MOOD DYSREGULATION DISORDER - A NEW AND CHALLENGING DIAGNOSIS IN DSM-5].
2018,
Pubmed
Hasin,
Epidemiology of Adult DSM-5 Major Depressive Disorder and Its Specifiers in the United States.
2018,
Pubmed
Hettema,
What is the genetic relationship between anxiety and depression?
2008,
Pubmed
Hirshler,
Neuroplasticity-related mechanisms underlying the antidepressant-like effects of traditional herbal medicines.
2017,
Pubmed
Huang,
Role of tandospirone, a 5-HT1A receptor partial agonist, in the treatment of central nervous system disorders and the underlying mechanisms.
2017,
Pubmed
James,
Effects of Selective Serotonin Reuptake Inhibitors on Interregional Relation of Serotonin Transporter Availability in Major Depression.
2017,
Pubmed
Joshi,
Selective Serotonin Re-uptake Inhibitors: An overview.
2018,
Pubmed
Jurikova,
Polyphenolic profile and biological activity of Chinese hawthorn (Crataegus pinnatifida BUNGE) fruits.
2012,
Pubmed
Katzman,
Current considerations in the treatment of generalized anxiety disorder.
2009,
Pubmed
LOWRY,
Protein measurement with the Folin phenol reagent.
1951,
Pubmed
Lee,
Monoamine oxidase B and free radical scavenging activities of natural flavonoids in Melastoma candidum D. Don.
2001,
Pubmed
Lim,
Chlorogenic Acid from Hawthorn Berry (Crataegus pinnatifida Fruit) Prevents Stress Hormone-Induced Depressive Behavior, through Monoamine Oxidase B-Reactive Oxygen Species Signaling in Hippocampal Astrocytes of Mice.
2018,
Pubmed
Lin,
Inhibition of monoamine oxidase B (MAO-B) by Chinese herbal medicines.
2003,
Pubmed
Masand,
Long-term side effects of newer-generation antidepressants: SSRIS, venlafaxine, nefazodone, bupropion, and mirtazapine.
2002,
Pubmed
Mathers,
Projections of global mortality and burden of disease from 2002 to 2030.
2006,
Pubmed
Miranda,
Brain-Derived Neurotrophic Factor: A Key Molecule for Memory in the Healthy and the Pathological Brain.
2019,
Pubmed
Murrough,
Emerging drugs for the treatment of anxiety.
2015,
Pubmed
Parit,
Nutritional Quality and Antioxidant Activity of Wheatgrass (Triticum aestivum) Unwrap by Proteome Profiling and DPPH and FRAP assays.
2018,
Pubmed
Peng,
Anxiolytic effect of seed of Ziziphus jujuba in mouse models of anxiety.
2000,
Pubmed
Prenner,
Reduction of high-affinity beta2-adrenergic receptor binding by hyperforin and hyperoside on rat C6 glioblastoma cells measured by fluorescence correlation spectroscopy.
2007,
Pubmed
Ran,
YL-0919, a dual 5-HT1A partial agonist and SSRI, produces antidepressant- and anxiolytic-like effects in rats subjected to chronic unpredictable stress.
2018,
Pubmed
Ravindran,
The pharmacologic treatment of anxiety disorders: a review of progress.
2010,
Pubmed
Rayner,
Antidepressants for the treatment of depression in palliative care: systematic review and meta-analysis.
2011,
Pubmed
Reinhold,
Pharmacological treatment of generalized anxiety disorder.
2011,
Pubmed
Reshef,
The Effects of Acupuncture Treatment on Sleep Quality and on Emotional Measures among Individuals Living with Schizophrenia: A Pilot Study.
2013,
Pubmed
Robinson,
Clinical effects of the 5-HT1A partial agonists in depression: a composite analysis of buspirone in the treatment of depression.
1990,
Pubmed
Singhuber,
GABA(A) receptor modulators from Chinese herbal medicines traditionally applied against insomnia and anxiety.
2012,
Pubmed
,
Xenbase
Taylor,
COVID stress syndrome: Concept, structure, and correlates.
2020,
Pubmed
Tran,
5-HT1A receptor agonist 8-OH-DPAT induces serotonergic behaviors in mice via interaction between PKCδ and p47phox.
2019,
Pubmed
Vorobiov,
Coupling of the muscarinic m2 receptor to G protein-activated K(+) channels via Galpha(z) and a receptor-Galpha(z) fusion protein. Fusion between the receptor and Galpha(z) eliminates catalytic (collision) coupling.
2000,
Pubmed
,
Xenbase
Wang,
Exercise-induced brain-derived neurotrophic factor expression: Therapeutic implications for Alzheimer's dementia.
2018,
Pubmed
Wang,
Review of antidepressants in clinic and active ingredients of traditional Chinese medicine targeting 5-HT1A receptors.
2019,
Pubmed
Weizman,
Serotonin transporter polymorphism and response to SSRIs in major depression and relevance to anxiety disorders and substance abuse.
2000,
Pubmed
Williams,
Quantitative analysis of immunolabeling for serotonin and for glutamate transporters after administration of imipramine and citalopram.
2005,
Pubmed
Wojakowska,
Structural characterization of flavonoid glycosides from leaves of wheat (Triticum aestivum L.) using LC/MS/MS profiling of the target compounds.
2013,
Pubmed
Wu,
Roles and Mechanisms of Hawthorn and Its Extracts on Atherosclerosis: A Review.
2020,
Pubmed
Wu,
Sex-specific and region-specific changes in BDNF-TrkB signalling in the hippocampus of 5-HT1A receptor and BDNF single and double mutant mice.
2012,
Pubmed
Zhang,
A systems-based analysis to explore the multiple mechanisms of Shan Zha for treating human diseases.
2021,
Pubmed
Zhou,
Genus Lilium: A review on traditional uses, phytochemistry and pharmacology.
2021,
Pubmed
de Jong,
Effects of chronic treatment with fluvoxamine and paroxetine during adolescence on serotonin-related behavior in adult male rats.
2006,
Pubmed
